Ads
related to: pembrolizumab and nivolumab- Side Effects
Learn About Possible Side Effects
at the Official Patient Site.
- What Is KEYTRUDA?
Learn About What KEYTRUDA Is & How
It May Help Eligible Patients.
- Taking KEYTRUDA?
Learn What to Expect When
Taking KEYTRUDA.
- Treatment Options
Learn About Treatment
Options With KEYTRUDA.
- Clinical Trial Results
See Clinical Trial Results
at the Official Site.
- Get Financial Help
Find Assistance and Payment
Information for Eligible Patients.
- Side Effects
Search results
New drug for cervical cancer patients approved for use in NHS in Scotland
Press Association News via AOL· 1 year agoScotland has become the the first part of the UK to make a new treatment for women with advanced...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 9 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
Benzinga via Yahoo Finance· 2 years agoNanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime...
New ways to treat bladder cancer improve survival and shake up the standard of care, new studies...
CNN via Yahoo News· 7 months agoA new combination of cancer medications has been shown in research to extend overall survival in...
SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian...
Benzinga via Yahoo Finance· 2 years agoSELLAS Life Sciences Group Inc (NASDAQ: SLS) announced confirmatory topline data from the final...
OncoSec Shares Disappointing Results From Skin Cancer Combo Therapy Trial, Sets Stage For...
Benzinga via Yahoo Finance· 1 year agoOncoSec Medical Incorporated (NASDAQ: ONCS) shares plummeted Monday following Phase 2 KEYNOTE-695...
Looking to the future Cancer specialists optimistic about expanded melanoma treatments
The Ledger via Yahoo News· 2 years agoThe past decade was an exciting time for patients diagnosed with advanced melanoma, the least common...
Gilead (GILD), Arcus Announce Results From Mid-Stage NSCLC Study
Zacks via Yahoo Finance· 12 months agoGilead Sciences, Inc. GILD and partner Arcus Biosciences, Inc. RCUS announced encouraging updated...
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
At R&D Day, Alpine Immune Highlights Updates On Autoimmune, Immuno-Oncology Programs
Benzinga via Yahoo Finance· 2 years agoAlpine Immune Sciences Inc (NASDAQ: ALPN) announced clinical updates from ALPN-303 and davoceticept...
Ads
related to: pembrolizumab and nivolumab